Literature DB >> 24559768

Development of tag-free photoprobes for studies aimed at identifying the target of novel Group A Streptococcus antivirulence agents.

Bryan D Yestrepsky1, Colin A Kretz2, Yuanxi Xu3, Autumn Holmes2, Hongmin Sun3, David Ginsburg2, Scott D Larsen4.   

Abstract

We previously reported the identification and development of novel inhibitors of streptokinase (SK) expression by Group A Streptococcus (GAS), originating from a high throughput cell-based phenotypic screen. Although phenotypic screening is well-suited to identifying compounds that exert desired biological effects in potentially novel ways, it requires follow-up experiments to determine the macromolecular target(s) of active compounds. We therefore designed and synthesized several classes of chemical probes for target identification studies, guided by previously established structure-activity relationships. The probes were designed to first irreversibly photolabel target proteins in the intact bacteria, followed by cell lysis and click ligation with fluorescent tags to allow for visualization on SDS-PAGE gels. This stepwise, 'tag-free' approach allows for a significant reduction in molecular weight and polar surface area compared to full-length fluorescent or biotinylated probes, potentially enhancing membrane permeability and the maintenance of activity. Of the seven probes produced, the three most biologically active were employed in preliminary target identification trials. Despite the potent activity of these probes, specific labeling events were not conclusively observed due to a considerable degree of nonspecific protein binding. Nevertheless, the successful synthesis of potent biologically active probe molecules will serve as a starting point for initiating more sensitive methods of probe-based target identification.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic; Click chemistry; Group A Streptococcus; Phenotypic screening; Photo-crosslinking; Streptokinase; Tag-free photoprobes; Target identification; Virulence inhibitor

Mesh:

Substances:

Year:  2014        PMID: 24559768      PMCID: PMC4005860          DOI: 10.1016/j.bmcl.2014.01.079

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  28 in total

Review 1.  Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions.

Authors:  Bernd Kreikemeyer; Kevin S McIver; Andreas Podbielski
Journal:  Trends Microbiol       Date:  2003-05       Impact factor: 17.079

Review 2.  Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Authors:  David J Payne; Michael N Gwynn; David J Holmes; David L Pompliano
Journal:  Nat Rev Drug Discov       Date:  2006-12-08       Impact factor: 84.694

3.  Identifying the proteins to which small-molecule probes and drugs bind in cells.

Authors:  Shao-En Ong; Monica Schenone; Adam A Margolin; Xiaoyu Li; Kathy Do; Mary K Doud; D R Mani; Letian Kuai; Xiang Wang; John L Wood; Nicola J Tolliday; Angela N Koehler; Lisa A Marcaurelle; Todd R Golub; Robert J Gould; Stuart L Schreiber; Steven A Carr
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

Review 4.  Anti-virulence strategies to combat bacteria-mediated disease.

Authors:  David A Rasko; Vanessa Sperandio
Journal:  Nat Rev Drug Discov       Date:  2010-01-18       Impact factor: 84.694

Review 5.  How were new medicines discovered?

Authors:  David C Swinney; Jason Anthony
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

6.  A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B.

Authors:  A Heath; V J DiRita; N L Barg; N C Engleberg
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Development of the first potential covalent inhibitors of anandamide cellular uptake.

Authors:  Aniello Schiano Moriello; Laurence Balas; Alessia Ligresti; Maria Grazia Cascio; Thierry Durand; Enrico Morera; Giorgio Ortar; Vincenzo Di Marzo
Journal:  J Med Chem       Date:  2006-04-06       Impact factor: 7.446

8.  Role of mga in growth phase regulation of virulence genes of the group A streptococcus.

Authors:  K S McIver; J R Scott
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

9.  Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.

Authors:  Hongmin Sun; Ulrika Ringdahl; Jonathon W Homeister; William P Fay; N Cary Engleberg; Angela Y Yang; Laura S Rozek; Xixi Wang; Ulf Sjöbring; David Ginsburg
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

10.  Global analysis of protein expression in yeast.

Authors:  Sina Ghaemmaghami; Won-Ki Huh; Kiowa Bower; Russell W Howson; Archana Belle; Noah Dephoure; Erin K O'Shea; Jonathan S Weissman
Journal:  Nature       Date:  2003-10-16       Impact factor: 49.962

View more
  1 in total

1.  Linoleic and palmitoleic acid block streptokinase-mediated plasminogen activation and reduce severity of invasive group A streptococcal infection.

Authors:  Katharina Rox; Rolf Jansen; Torsten G Loof; Christine M Gillen; Steffen Bernecker; Mark J Walker; Gursharan Singh Chhatwal; Rolf Müller
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.